Too little sleep may trigger the 'munchies' by raising levels of an appetite-controlling molecule

June 15, 2013

SAN FRANCISCO--Insufficient sleep may contribute to weight gain and obesity by raising levels of a substance in the body that is a natural appetite stimulant, a new study finds. The results were presented today at The Endocrine Society's 95th Annual Meeting in San Francisco.

The researchers found that when healthy, lean, young adults received only 4.5 hours of sleep a night, they had higher daytime circulating, or blood, levels of a molecule that controls the pleasurable aspects of eating, compared with when they slept 8.5 hours.

"Past experimental studies show that sleep restriction increases hunger and appetite," said Erin Hanlon, PhD, research associate (assistant professor) at the University of Chicago's Section of Endocrinology, Diabetes and Metabolism. "The mechanism for overeating after inadequate sleep may be an elevation in this endocannabinoid molecule, called 2-arachidonoylglycerol, or 2-AG."

With colleagues from the University of Chicago Medicine and the Medical College of Wisconsin in Milwaukee, Hanlon studied nine subjects with an average age of 23 years. The subjects spent six nights in a sleep lab and then another six nights there at least a month later. In a random order, the subjects were allowed to sleep from 11 p.m. to 7:30 a.m. ("normal sleep - 8.5 hours in bed") during one testing period and from 1 to 5:30 a.m. ("partial sleep restriction - 4.5 hours in bed") during the other testing period. During waking hours, the subjects ate a controlled number of calories based on their height and weight.

After the second night of each sleep condition, the researchers took blood samples from the subjects at one-hour intervals for 24 hours. Using a highly accurate laboratory assay, they analyzed the samples for 2-AG, a component of the endocannabinoid system. Found throughout the body, this system plays an important role in the signaling of rewarding events and one's enjoyment of eating, similar to the cannabinoids in marijuana, Hanlon said.

Levels of 2-AG levels were the lowest halfway through sleep and the highest in the early afternoon, "when the pleasurable properties of food would be most beneficial," Hanlon said. She reported that the afternoon peak of 2-AG was even higher when the study participants had partial sleep restriction than when they had normal sleep.

The study results suggest that the increased hunger and appetite that subjects in previous studies have reported after sleep restriction might be due to increases in circulating 2-AG, she said.

"These findings," Hanlon said, "are highly relevant to millions of individuals who are at an increased risk of obesity and its health consequences because of chronic short sleep or sleep disruption."

This study received funding from the National Institutes of Health, the Department of Defense Peer Reviewed Medical Program and the Advancing a Healthier Wisconsin endowment fund of the Medical College of Wisconsin.
-end-
Founded in 1916, The Endocrine Society is the world's oldest, largest and most active organization devoted to research on hormones and the clinical practice of endocrinology. Today, The Endocrine Society's membership consists of over 16,000 scientists, physicians, educators, nurses and students in more than 100 countries. Society members represent all basic, applied and clinical interests in endocrinology. The Endocrine Society is based in Chevy Chase, Maryland. To learn more about the Society and the field of endocrinology, visit our site at http://www.endocrine.org. Follow us on Twitter.

The Endocrine Society

Related Obesity Articles from Brightsurf:

11 years of data add to the evidence for using testosterone therapy to treat obesity, including as an alternative to obesity surgery
New research covering 11 years of data presented at this year's European and International Congress on Obesity (ECOICO 2020) show that, in obese men suffering from hypogonadism (low testosterone), treatment with testosterone injections lowers their weight and improves a wide range of other metabolic parameters.

Overlap between immunology of COVID-19 and obesity could explain the increased risk of death in people living with obesity, and also older patients
Data presented in a special COVID-19 session at the European and International Congress on Obesity (ECOICO 2020) suggests that there are overlaps between the immunological disturbances found in both COVID-19 disease and patients with obesity, which could explain the increased disease severity and mortality risk faced by obese patients, and also elderly patients, who are infected by the SARS-CoV-2 virus that causes COVID-19 disease.

New obesity guideline: Address root causes as foundation of obesity management
besity management should focus on outcomes that patients consider to be important, not weight loss alone, and include a holistic approach that addresses the root causes of obesity, according to a new clinical practice guideline published in CMAJ (Canadian Medical Association Journal) http://www.cmaj.ca/lookup/doi/10.1503/cmaj.191707.

Changing the debate around obesity
The UK's National Health Service (NHS) needs to do more to address the ingrained stigma and discrimination faced by people with obesity, says a leading health psychologist.

Study links longer exposure to obesity and earlier development of obesity to increased risk of type 2 diabetes
Cumulative exposure to obesity could be at least as important as actually being obese in terms of risk of developing type 2 diabetes (T2D), concludes new research published in Diabetologia (the journal of the European Association for the Study of Diabetes [EASD]).

How much do obesity and addictions overlap?
A large analysis of personality studies has found that people with obesity behave somewhat like people with addictions to alcohol or drugs.

Should obesity be recognized as a disease?
With obesity now affecting almost a third (29%) of the population in England, and expected to rise to 35% by 2030, should we now recognize it as a disease?

Is obesity associated with risk of pediatric MS?
A single-center study of 453 children in Germany with multiple sclerosis (MS) investigated the association of obesity with pediatric MS risk and with the response of first-line therapy in children with MS.

Women with obesity prior to conception are more likely to have children with obesity
A systematic review and meta-analysis identified significantly increased odds of child obesity when mothers have obesity before conception, according to a study published June 11, 2019 in the open-access journal PLOS Medicine by Nicola Heslehurst of Newcastle University in the UK, and colleagues.

Obesity medicine association announces major updates to its adult obesity algorithm
The Obesity Medicine Association (OMA) announced the immediate availability of the 2019 OMA Adult Obesity Algorithm, with new information for clinicians including the relationship between Obesity and Cardiovascular Disease, Diabetes Mellitus, Dyslipidemia, and Cancer; information on investigational Anti-Obesity Pharmacotherapy; treatments for Lipodystrophy; and Pharmacokinetics and Obesity.

Read More: Obesity News and Obesity Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.